Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015

Introduction Cardiovascular (CV) disease affects a high percentage of patients with type 2 diabetes mellitus (T2DM), especially in the hospital setting, impacting on mortality, complications, quality of life and use of health resources. The aim of this study was to estimate the incidence, mean lengt...

Full description

Bibliographic Details
Main Authors: Esteban Jodar, Sara Artola, Xavier Garcia-Moll, Estefany Uría, Noemí López-Martínez, Rosa Palomino, Virginia Martín
Format: Article
Language:English
Published: BMJ Publishing Group 2020-04-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/8/1/e001130.full
id doaj-3c1ad0a44da5424d92327c6ee44d5e85
record_format Article
spelling doaj-3c1ad0a44da5424d92327c6ee44d5e852021-06-10T10:07:37ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972020-04-018110.1136/bmjdrc-2019-001130Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015Esteban Jodar0Sara Artola1Xavier Garcia-Moll2Estefany Uría3Noemí López-Martínez4Rosa Palomino5Virginia Martín6Department of Endocrinology and Nutrition, Quirón Salud Madrid and Ruber Juan Bravo University Hospitals, Universidad Europea de Madrid, Madrid, SpainJosé Marvá Health Centre, RedGDPS Foundation, Madrid, SpainCardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, IIB-Sant Pau Research Institute, Universitat Autònoma de Barcelona, Barcelona, SpainOblikue Consulting, S.L, Barcelona, SpainOblikue Consulting, S.L, Barcelona, SpainOblikue Consulting, S.L, Barcelona, SpainNovo Nordisk Pharma SA, Madrid, SpainIntroduction Cardiovascular (CV) disease affects a high percentage of patients with type 2 diabetes mellitus (T2DM), especially in the hospital setting, impacting on mortality, complications, quality of life and use of health resources. The aim of this study was to estimate the incidence, mean length of hospital stay (LOHS) and costs attributable to hospital admissions due to CV events in patients with T2DM versus patients without diabetes mellitus (non-DM) in Spain.Research design and methods Retrospective observational study based on the Spanish National Hospital Discharge Database for 2015. Hospital admissions for patients aged ≥35 years with a diagnosis of CV death, non-fatal acute myocardial infarction (AMI), non-fatal stroke, unstable angina, heart failure and revascularization were evaluated. The International Classification of Diseases, Ninth Revision (250.x0 or 250.x2) coding was used to classify records of patients with T2DM. For each CV complication, the hospital discharges of the two groups, T2DM and non-DM, were precisely matched and the number of hospital discharges, patients, LOHS and mean cost were quantified. Additional analyses assessed the robustness of the results.Results Of the 276 925 hospital discharges analyzed, 34.71% corresponded to patients with T2DM. A higher incidence was observed in all the CV complications studied in the T2DM population, with a relative risk exceeding 2 in all cases. The mean LOHS (days) was longer in the T2DM versus the non-DM group for: non-fatal AMI (7.63 vs 7.02, p<0.001), unstable angina (5.11 vs 4.78, p=0.009) and revascularization (7.96 vs 7.57, p<0.001). The mean cost per hospital discharge was higher in the T2DM versus the non-DM group for non-fatal AMI (€6891 vs €6876, p=0.029) and unstable angina (€3386 vs €3304, p<0.001).Conclusions Patients with T2DM had a higher incidence and number of hospital admissions per patient due to CV events versus the non-DM population. This generates a significant clinical and economic burden given the longer admission stay and higher costs associated with some of these complications.https://drc.bmj.com/content/8/1/e001130.full
collection DOAJ
language English
format Article
sources DOAJ
author Esteban Jodar
Sara Artola
Xavier Garcia-Moll
Estefany Uría
Noemí López-Martínez
Rosa Palomino
Virginia Martín
spellingShingle Esteban Jodar
Sara Artola
Xavier Garcia-Moll
Estefany Uría
Noemí López-Martínez
Rosa Palomino
Virginia Martín
Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
BMJ Open Diabetes Research & Care
author_facet Esteban Jodar
Sara Artola
Xavier Garcia-Moll
Estefany Uría
Noemí López-Martínez
Rosa Palomino
Virginia Martín
author_sort Esteban Jodar
title Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
title_short Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
title_full Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
title_fullStr Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
title_full_unstemmed Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
title_sort incidence and costs of cardiovascular events in spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
publisher BMJ Publishing Group
series BMJ Open Diabetes Research & Care
issn 2052-4897
publishDate 2020-04-01
description Introduction Cardiovascular (CV) disease affects a high percentage of patients with type 2 diabetes mellitus (T2DM), especially in the hospital setting, impacting on mortality, complications, quality of life and use of health resources. The aim of this study was to estimate the incidence, mean length of hospital stay (LOHS) and costs attributable to hospital admissions due to CV events in patients with T2DM versus patients without diabetes mellitus (non-DM) in Spain.Research design and methods Retrospective observational study based on the Spanish National Hospital Discharge Database for 2015. Hospital admissions for patients aged ≥35 years with a diagnosis of CV death, non-fatal acute myocardial infarction (AMI), non-fatal stroke, unstable angina, heart failure and revascularization were evaluated. The International Classification of Diseases, Ninth Revision (250.x0 or 250.x2) coding was used to classify records of patients with T2DM. For each CV complication, the hospital discharges of the two groups, T2DM and non-DM, were precisely matched and the number of hospital discharges, patients, LOHS and mean cost were quantified. Additional analyses assessed the robustness of the results.Results Of the 276 925 hospital discharges analyzed, 34.71% corresponded to patients with T2DM. A higher incidence was observed in all the CV complications studied in the T2DM population, with a relative risk exceeding 2 in all cases. The mean LOHS (days) was longer in the T2DM versus the non-DM group for: non-fatal AMI (7.63 vs 7.02, p<0.001), unstable angina (5.11 vs 4.78, p=0.009) and revascularization (7.96 vs 7.57, p<0.001). The mean cost per hospital discharge was higher in the T2DM versus the non-DM group for non-fatal AMI (€6891 vs €6876, p=0.029) and unstable angina (€3386 vs €3304, p<0.001).Conclusions Patients with T2DM had a higher incidence and number of hospital admissions per patient due to CV events versus the non-DM population. This generates a significant clinical and economic burden given the longer admission stay and higher costs associated with some of these complications.
url https://drc.bmj.com/content/8/1/e001130.full
work_keys_str_mv AT estebanjodar incidenceandcostsofcardiovasculareventsinspanishpatientswithtype2diabetesmellitusacomparisonwithgeneralpopulation2015
AT saraartola incidenceandcostsofcardiovasculareventsinspanishpatientswithtype2diabetesmellitusacomparisonwithgeneralpopulation2015
AT xaviergarciamoll incidenceandcostsofcardiovasculareventsinspanishpatientswithtype2diabetesmellitusacomparisonwithgeneralpopulation2015
AT estefanyuria incidenceandcostsofcardiovasculareventsinspanishpatientswithtype2diabetesmellitusacomparisonwithgeneralpopulation2015
AT noemilopezmartinez incidenceandcostsofcardiovasculareventsinspanishpatientswithtype2diabetesmellitusacomparisonwithgeneralpopulation2015
AT rosapalomino incidenceandcostsofcardiovasculareventsinspanishpatientswithtype2diabetesmellitusacomparisonwithgeneralpopulation2015
AT virginiamartin incidenceandcostsofcardiovasculareventsinspanishpatientswithtype2diabetesmellitusacomparisonwithgeneralpopulation2015
_version_ 1721385129110142976